These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Follicular dendritic cell sarcoma of the porta hepatis. Patel JA; Piper JB; Wang BG BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29437813 [TBL] [Abstract][Full Text] [Related]
3. Histiocytic and follicular dendritic cell sarcoma: Diagnostically challenging rare entities. Patra S; Trivedi P; Kaur K Indian J Pathol Microbiol; 2021; 64(2):316-322. PubMed ID: 33851626 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis. Takahashi M; Komine K; Imai H; Okada Y; Saijo K; Takahashi M; Shirota H; Ohori H; Takahashi S; Chiba N; Mori T; Shimodaira H; Ishioka C PLoS One; 2017; 12(5):e0176972. PubMed ID: 28489919 [TBL] [Abstract][Full Text] [Related]
6. Docetaxel and gemcitabine released for cancer chemotherapy. Am J Health Syst Pharm; 1996 Jul; 53(14):1643, 1649. PubMed ID: 8827226 [No Abstract] [Full Text] [Related]
7. Extranodal Follicular dendritic cell sarcoma presenting as a rectal polyp: An entity overlooked by its differentials. Gurung N; Mukherjee U; Khurana A Indian J Pathol Microbiol; 2021; 64(4):814-816. PubMed ID: 34673612 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients. Tanaka K; Joyama S; Chuman H; Hiraga H; Morioka H; Yoshikawa H; Hosaka M; Takahashi M; Kubo T; Hatano H; Kaya M; Toguchida J; Nishida Y; Nagano A; Tsumura H; Iwamoto Y World J Surg Oncol; 2016 Dec; 14(1):306. PubMed ID: 27931230 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma]. Yao Z; Yang S; Zhao Y; Yao S; Guo H; Liu Y Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):541-5. PubMed ID: 25327662 [TBL] [Abstract][Full Text] [Related]
10. [Extranodal follicular dendritic cell sarcoma of neck region: report of a case]. Xu XF; Zhang XJ Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):410-1. PubMed ID: 22932412 [No Abstract] [Full Text] [Related]
11. [Follicular dendritic cell sarcoma of stomach: report of a case]. Wang LF; Wang RF; Wang ZC; Han W; Mei HL; Liu M Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):210-1. PubMed ID: 18788606 [No Abstract] [Full Text] [Related]
12. Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group. Skarlos DV; Dimopoulos AM; Kosmidis P; Papakostas P; Pavlidis N; Bacoyiannis C; Kiamouris C; Klouvas G; Gogas H; Fountzilas G; Samantas E; Lung Cancer; 2003 Jul; 41(1):107-11. PubMed ID: 12826319 [TBL] [Abstract][Full Text] [Related]
13. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma]. Longo F; Mansueto G Tumori; 2004; 90(5):1-8. PubMed ID: 15656346 [No Abstract] [Full Text] [Related]
14. Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma. Ridwelski K; Fahlke J; Kuhn R; Hribaschek A; Kettner E; Greiner C; Florschuetz A; Manger T; Wilhelm G; Klein H; Hahnfeld S; Lippert H; Meyer F Eur J Surg Oncol; 2006 Apr; 32(3):297-302. PubMed ID: 16414235 [TBL] [Abstract][Full Text] [Related]
15. Extranodal Follicular Dendritic Cell Sarcoma-A Review: "What the Mind Does Not Know the Eye Does Not See". Kaur R; Mehta J; Borges A Adv Anat Pathol; 2021 Jan; 28(1):21-29. PubMed ID: 32991350 [TBL] [Abstract][Full Text] [Related]
16. Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model. Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Nelson SD; Dry SM; Li Y; Russell TA; Singh AS; Chmielowski B; Unno M; Eilber FC; Hoffman RM Cell Cycle; 2017 Jun; 16(11):1063-1069. PubMed ID: 28426279 [TBL] [Abstract][Full Text] [Related]
17. TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group. Jørgensen CL; Bjerre C; Ejlertsen B; Bjerre KD; Balslev E; Bartels A; Brünner N; Nielsen DL BMC Cancer; 2014 May; 14():360. PubMed ID: 24884504 [TBL] [Abstract][Full Text] [Related]
18. Follicular dendritic cell sarcoma of the neck with pulmonary metastases. Fareed MM; Memon MA; Rashid A; Furrukh M; Ahmed S; Ghouri AR; Khan A; Asghar AS J Coll Physicians Surg Pak; 2011 Sep; 21(9):561-3. PubMed ID: 21914416 [TBL] [Abstract][Full Text] [Related]
19. The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors. Dumez H; Louwerens M; Pawinsky A; Planting AS; de Jonge MJ; Van Oosterom AT; Highley M; Guetens G; Mantel M; de Boeck G; de Bruijn E; Verweij J Anticancer Drugs; 2002 Jul; 13(6):583-93. PubMed ID: 12172503 [TBL] [Abstract][Full Text] [Related]
20. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial. Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]